Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States

25Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Objective: To characterize the contemporary efficacy and utilization patterns of coronary artery bypass grafting (CABG) in specific cancer types. Methods: We leveraged the data from the National Inpatient Sample and plotted trends of utilization and outcomes of isolated CABG (with no other additional surgeries during the same hospitalization) procedures from January 1, 2003, through September 1, 2015. Propensity score matching was used to assess for potential differences in outcomes by type of cancer status among contemporary (2012–2015) patients. Results: Overall, the utilization of CABG decreased over time (250,677 in 2003 vs 134,534 in 2015, P .05). However, there was a significantly higher prevalence of major bleeding but not stroke in patients with breast and prostate cancer only compared with non-cancer CABG patients (P.05), except for breast cancer patients who had lower home care, but higher skilled care disposition (P

Cite

CITATION STYLE

APA

Guha, A., Dey, A. K., Kalra, A., Gumina, R., Lustberg, M., Lavie, C. J., … Addison, D. (2020). Coronary Artery Bypass Grafting in Cancer Patients: Prevalence and Outcomes in the United States. Mayo Clinic Proceedings, 95(9), 1865–1876. https://doi.org/10.1016/j.mayocp.2020.05.044

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free